Pujol-Pujol, M.; Rivero-Martínez, M.; Puente, J.; Vidal, N.; Calvo, M.; Riaza, C.; Álvarez-Nadal, M.; Rodríguez-Moreno, A.; Sánchez-Fructuoso, A.I.; García-Carro, C. Abiraterone-Associated Renal Damage in Patients with Advanced Prostate Cancer as a Risk Factor for Mortality and Chronic Kidney Disease. J. Clin. Med. 2025, 14, 7559. https://doi.org/10.3390/jcm14217559

AMA Style

Pujol-Pujol M, Rivero-Martínez M, Puente J, Vidal N, Calvo M, Riaza C, Álvarez-Nadal M, Rodríguez-Moreno A, Sánchez-Fructuoso AI, García-Carro C. Abiraterone-Associated Renal Damage in Patients with Advanced Prostate Cancer as a Risk Factor for Mortality and Chronic Kidney Disease. Journal of Clinical Medicine. 2025; 14(21):7559. https://doi.org/10.3390/jcm14217559

Chicago/Turabian Style

Pujol-Pujol, Marina, Marta Rivero-Martínez, Javier Puente, Natalia Vidal, Marta Calvo, Cristina Riaza, Marta Álvarez-Nadal, Antolina Rodríguez-Moreno, Ana I. Sánchez-Fructuoso, and Clara García-Carro. 2025. "Abiraterone-Associated Renal Damage in Patients with Advanced Prostate Cancer as a Risk Factor for Mortality and Chronic Kidney Disease" Journal of Clinical Medicine 14, no. 21: 7559. https://doi.org/10.3390/jcm14217559

APA Style

Pujol-Pujol, M., Rivero-Martínez, M., Puente, J., Vidal, N., Calvo, M., Riaza, C., Álvarez-Nadal, M., Rodríguez-Moreno, A., Sánchez-Fructuoso, A. I., & García-Carro, C. (2025). Abiraterone-Associated Renal Damage in Patients with Advanced Prostate Cancer as a Risk Factor for Mortality and Chronic Kidney Disease. Journal of Clinical Medicine, 14(21), 7559. https://doi.org/10.3390/jcm14217559

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

For more information on the journal statistics, click here.

Multiple requests from the same IP address are counted as one view.

Article Menu

Article Versions Notes

Further Information

Guidelines

MDPI Initiatives

Follow MDPI